Pharma faces more deceptive-marketing charges from states

04/23/2013 | Wall Street Journal, The

The pharmaceutical industry's potential liability widened after some U.S. states showed more aggressiveness in accusing drugmakers of deceptive marketing. Certain states have opted to act alone, which has led to heavy settlements and single-state awards. PhRMA Senior Vice President Matthew Bennett said "imposing state-law penalties on manufacturers for alleged violations of [federal drug law] raises serious legal and constitutional questions."

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC